To correlate the reduction in cancer stem cell marker expression in Pa00 cells (Figure 4) with decreased tumorigenicity (function), xenograft tests were carried out by injecting BCRP1-positive cells previously treated with CTE. This evidence concerns the gene BCRP1 and cancer.